The TB structural genomics consortium: a resource for Mycobacterium tuberculosis biology.
about
targetTB: a target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysisStructure of the C-terminal domain of the arginine repressor protein fromMycobacterium tuberculosisCrystalDirect: a new method for automated crystal harvesting based on laser-induced photoablation of thin filmsStructure of arylamine N-acetyltransferase from Mycobacterium tuberculosis determined by cross-seeding with the homologous protein from M. marinum: triumph over adversityMolecular flexibility of Mycobacterium tuberculosis ribosome recycling factor and its functional consequences: an exploration involving mutantsStructural studies on Mycobacterium tuberculosis RecA: molecular plasticity and interspecies variabilityStructural plasticity in Mycobacterium tuberculosis uracil-DNA glycosylase (MtUng) and its functional implicationsPrioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosisThe Mycobacterium tuberculosis drugome and its polypharmacological implicationsThe molecular structure of Rv2074, a probable pyridoxine 5'-phosphate oxidase from Mycobacterium tuberculosis, at 1.6 angstroms resolutionPreliminary X-ray crystallographic analysis of ornithine acetyltransferase (Rv1653) from Mycobacterium tuberculosisCharacterization of phylogenetically distant members of the adenylate cyclase family from mycobacteria: Rv1647 from Mycobacterium tuberculosis and its orthologue ML1399 from M. lepraeBenefits of structural genomics for drug discovery researchSolution structure of the conserved hypothetical protein Rv2302 from Mycobacterium tuberculosis.Detecting remotely related proteins by their interactions and sequence similarityComputational databases, pathway and cheminformatics tools for tuberculosis drug discovery.Expression, purification and preliminary crystallographic analysis of O-acetylhomoserine sulfhydrylase from Mycobacterium tuberculosis.Structural genomics of infectious disease drug targets: the SSGCID.The TB Structural Genomics Consortium: a decade of progress.Expression, purification, crystallization and preliminary X-ray analysis of two arginine-biosynthetic enzymes from Mycobacterium tuberculosis.The molecular structure of Rv1873, a conserved hypothetical protein from Mycobacterium tuberculosis, at 1.38 A resolution.Expression, purification and preliminary X-ray analysis of the C-terminal domain of an arginine repressor protein from Mycobacterium tuberculosis.Cloning, expression, purification, crystallization and preliminary X-ray crystallographic analysis of bacterioferritin A from Mycobacterium tuberculosisSo how do you know you have a macromolecular complex?TB database: an integrated platform for tuberculosis researchHigh-throughput computational and experimental techniques in structural genomics.Recent advances in antituberculous drug development and novel drug targets.Production of recombinant proteins in Mycobacterium smegmatis for structural and functional studies.Molecular modeling studies of Fatty acyl-CoA synthetase (FadD13) from Mycobacterium tuberculosis--a potential target for the development of antitubercular drugs.Development of new antituberculous agents based on new drug targets and structure-activity relationship.Characterization of the secreted chorismate mutase from the pathogen Mycobacterium tuberculosis.Expression, purification and preliminary crystallographic analysis of N-acetylglucosamine-1-phosphate uridylyltransferase from Mycobacterium tuberculosis.Cloning, expression, purification, crystallization and preliminary X-ray crystallographic analysis of initiation factor 1 from Mycobacterium tuberculosis.Cloning, expression, purification, crystallization and preliminary X-ray studies of epoxide hydrolases A and B from Mycobacterium tuberculosis.Expression, purification, crystallization and preliminary X-ray crystallographic analysis of pantothenate kinase from Mycobacterium tuberculosis.Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of Rv2827c from Mycobacterium tuberculosis.New active leads for tuberculosis booster drugs by structure-based drug discovery.Biochemical and structural studies of Mycobacterium smegmatis MutT1, a sanitization enzyme with unusual modes of association.Structure and interactions of RecA: plasticity revealed by molecular dynamics simulations.The crystal structure of the drug target Mycobacterium tuberculosis methionyl-tRNA synthetase in complex with a catalytic intermediate.
P2860
Q21202793-5E062710-E1AD-4A25-B4C0-AB606833A0F2Q27651601-111EA616-0978-4776-B90E-9DEFB95EDA9CQ27682336-F3220381-992A-4C78-AC1C-A772F08D9F35Q27685295-786EBF83-8250-431D-80DA-17BF953D5744Q27687784-D9E65163-3ED2-494D-9084-9ED20F8A7DEEQ27698104-BB53898B-588E-4586-91F2-F4C16B005035Q27701464-06E67B39-C365-40AE-B870-ECDF61FD0112Q28469010-2AFFBD70-1259-4842-9F43-9508E0537136Q28476004-B826E27B-974C-4BCD-B63C-7C5AA04EDA14Q28486514-868A29BC-A105-4A58-8A92-A520AEFE31B6Q28487298-7DA28E85-0EA9-4EEA-85FA-AA9B52A80962Q28487548-A60CB1CB-4150-4F28-B6E8-DC6994519F53Q28752276-AD178D86-2576-42AC-B42E-0052FB5A8A98Q30356048-FA5CC513-17E4-410F-938F-65B1935C9207Q33821576-9F1FCD07-669C-4577-8408-5EA5E4A1FB51Q34153280-C2738848-F312-4780-92B0-CE92BE374D8DQ35150375-8E761938-6C1E-4F04-AAB3-534E56BAA0D6Q35203441-2A37ABB4-2219-4BD5-AB74-E565BFBAE5F5Q35846941-6261BA7C-E827-486D-81D3-0FB709AB105EQ36426268-DFD280EF-806D-42FF-9323-C13F254148A4Q36426545-56FB855C-C41F-4925-B871-C382AE34EB3DQ36588463-F5EB26DF-6606-422B-950D-9F0E969788D8Q36646842-B0B84466-19E5-4802-9610-71DED9889384Q36681811-DD69F403-2040-4518-A94B-B5224B1AC402Q37202442-26D2C53D-4FBF-4E8B-B3DD-CE5E3E40F4C6Q37621425-7DF36838-5E9D-413A-AD0A-56EF1A4C629FQ37754884-DCEF1124-FED3-4F8B-AB4A-C66613704587Q38258837-1BAC2937-AE18-42E3-B96C-7ED89303501BQ38429871-3EFA59CF-643A-4D89-AA73-3426D1550BC2Q40138610-3F7CCA48-3783-481F-9F9D-EBF5842C40BBQ41394328-1E5D310F-C723-41C3-ADFB-207FCB7CADA8Q41828790-270F0391-D082-4197-9B10-D22B2BB0C867Q41995478-94FB547A-C147-456B-AE44-C805211535EDQ42040971-237652B3-0DCC-4A72-A605-D4457BC52F75Q42411739-40CA24AA-46B4-4DAA-BB5A-3E8012D1AFF1Q43044044-5FDB09FC-20FB-456A-B39F-6933C7817F51Q47813934-DE316E9E-FEBC-4D91-9991-F086B911C534Q51072300-F259772D-AEAB-48BF-8246-662FC9674134Q51220276-059C2729-61FE-4ADF-BC1C-C32C45DC5AE0Q52326869-1E4DA185-3694-4A39-8046-5C968D7FBF68
P2860
The TB structural genomics consortium: a resource for Mycobacterium tuberculosis biology.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The TB structural genomics consortium: a resource for Mycobacterium tuberculosis biology.
@ast
The TB structural genomics consortium: a resource for Mycobacterium tuberculosis biology.
@en
type
label
The TB structural genomics consortium: a resource for Mycobacterium tuberculosis biology.
@ast
The TB structural genomics consortium: a resource for Mycobacterium tuberculosis biology.
@en
prefLabel
The TB structural genomics consortium: a resource for Mycobacterium tuberculosis biology.
@ast
The TB structural genomics consortium: a resource for Mycobacterium tuberculosis biology.
@en
P2093
P50
P1433
P1476
The TB structural genomics consortium: a resource for Mycobacterium tuberculosis biology
@en
P2093
Anderson DH
Apostol MI
Berendzen J
De Rossi E
P304
P356
10.1016/S1472-9792(03)00051-9
P50
P577
2003-01-01T00:00:00Z